Concepedia

Tsutomu Mimoto

TM

Statistics

Publications

16

Citations

1.1K

H-Index

14

Active since

1989

Affiliations

Kyoto Pharmaceutical University(Current)

National Cancer Institute

Science Applications International Corporation (United States)

Japan Petroleum Energy Center

Sumitomo Dainippon Pharma (Japan)

Tsutomu Mimoto is an author at Kyoto Pharmaceutical University specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

1989–2010

16

Publications

16

Structure of HIV-1 protease with KNI-272, a tight-binding transition-state analog containing allophenylnorstatine

Eric T. Baldwin, Talapady N. Bhat, Sergei Gulnik et al. · Structure · 1995 · 166 citations · Full text

, , +14

Kynostatin (KNI-227 and -272, highly potent anti-HIV agents: conformationally constrained tripeptide inhibitors of HIV protease containing allophenylnorstatine.

Tsutomu Mimoto, Junya Imai, Sumitsugu Kisanuki et al. · Chemical and Pharmaceutical Bulletin · 1992 · 148 citations · Full text

, , +16

In vitro anti-human immunodeficiency virus (HIV) activities of transition state mimetic HIV protease inhibitors containing allophenylnorstatine

Seiji Kageyama, Tsutomu Mimoto, Yasuhiko Murakawa et al. · Antimicrobial Agents and Chemotherapy · 1993 · 111 citations · Full text

, , +11

JE-2147: A dipeptide protease inhibitor (PI) that potently inhibits multi-PI-resistant HIV-1

Kazuhisa Yoshimura, Ryohei Kato, Keisuke Yusa et al. · Proceedings of the National Academy of Sciences · 1999 · 108 citations

, , +16

KNI-102, a novel tripeptide HIV protease inhibitor containing allophenylnorstatine as a transition-state mimic.

Tsutomu Mimoto, Naoko Hattori, Sumitsugu Kisanuki et al. · Chemical and Pharmaceutical Bulletin · 1991 · 81 citations · Full text

, , +15

1–5 of 16